Medical Device News | MedTech Dive (2024)

  • ICU Medical to close Minnesota facility, cut 83 jobs

    The infusion pump maker has focused on consolidating service centers and manufacturing sites since it bought Smiths Medical in 2022.

    By Susan Kelly July 23, 2024

  • Cook Medical to sell reproductive health business to private equity firm

    Astorg intends to combine the Cook assets withHamilton Thorne, another reproductive health business it plans to buy.

    By Nick Paul Taylor July 23, 2024

  • Explore the Trendline➔

    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embraceartificial intelligence, there are still questions about how the new technologiesneed to be regulated and if they are effective.

    By MedTech Dive staff

  • FDA sends 2 warning letters after inspecting Chinese syringe manufacturers

    One warning letter covers the production of plastic syringes for Cardinal Health.

    By Nick Paul Taylor July 22, 2024

  • Q&A

    ‘Our next frontier is prediction’: Medtronic on AI and heart disease

    Stacey Churchwell, who leads the company’s cardiovascular diagnostics and services business, says artificial intelligence is reducing false positives in its insertable cardiac monitors, saving clinicians valuable time.

    By Susan Kelly July 22, 2024

  • Dental implant maker Osstem in talks to acquire Zimvie: report

    Bloomberg first reported M&A rumors in June when Zimvie was approached about a takeover.

    By Elise Reuter July 19, 2024

  • Intuitive’s da Vinci 5 robot launch ‘well ahead’ of Wall Street expectations

    Early customer feedback on the new robot suggests features such as improved ergonomics and vision technology are helping drive adoption, executives said.

    By Susan Kelly July 19, 2024

  • GE Healthcare to buy AI software from Intelligent Ultrasound for $51M

    After purchasingCaption Health last year, GE Healthcare plans to add another artificial intelligence acquisition to the company.

    By Nick Paul Taylor July 19, 2024

  • Abbott previews PFA, over-the-counter CGM markets

    Electrophysiology sales held up against rivals’ launches of pulsed field ablation systems. Meanwhile, Abbott is gauging sales of its first OTC CGMs.

    By Elise Reuter July 18, 2024

  • Deep Dive

    Medtech firms have cut more than 14,000 jobs in the past 18 months

    Diagnostics is the largest industry represented in the data, with more than 5,000 affected positions, according to MedTech Dive’s analysis.

    By Jasmine Ye Han , Ricky Zipp , Elise Reuter July 17, 2024

  • Qiagen to cut 175 employees, close Michigan PCR test plant

    The layoffs and plant closure are part of a restructuring plan that Qiagen estimates will cost about $400 million.

    By Elise Reuter July 17, 2024

  • CFO Joe Wolk told investors Wednesday that Johnson & Johnson’s medical device businessmissed the company’s 5%-7% growth forecast in the second quarter.

    By Ricky Zipp July 17, 2024

  • Masimo sues activist investor Politan, postpones annual meeting

    The latest turn in the recent drama comes days after proxy advisory firms ISS and Glass Lewis backed two Politan nominees for Masimo’s board.

    By Susan Kelly July 16, 2024

  • FDA creates communication ‘super office’ at CDRH

    The changes are part of a broader reorganization intended to increase organizational agility and help the agency meet user fee commitments.

    By Nick Paul Taylor July 16, 2024

  • The companies’ financial results will offer a glimpse at the current health of medtech markets.

    By Nick Paul Taylor July 16, 2024

  • Edwards to acquire Innovalve, stake in Affluent Medical

    The heart valve specialist said in a federal filing that it expects to pay $300 million in cash for Innovalve Bio Medical when the deal closes.

    By Susan Kelly July 15, 2024

  • Hamilton recalls ventilators that may fail to restart

    One death and one injury have been tied to the safety problem, the Food and Drug Administration said in a recall notice.

    By Nick Paul Taylor July 15, 2024

  • Element raises $277M to challenge Illumina in sequencing market

    The startup claims companies that choose its device over Illumina’s sequencer can save almost $1.5 million in three years.

    By Nick Paul Taylor July 12, 2024

  • The FDA said 15 injuries have been tied to the use of three models of Megadyne patient return electrodes.

    By Elise Reuter July 12, 2024

  • FDA finalizes guidance on studying opioid use disorder treatments

    The Center for Devices and Radiological Health is aiming to help companies manage challenges such as inaccurate participant reports of drug use.

    By Nick Paul Taylor July 12, 2024

  • Deep Dive

    FDA’s lab developed test rule could be first check on agency’s power post-Chevron

    The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.

    By Susan Kelly , Elise Reuter July 11, 2024

  • FDA warns BD blood culture bottle shortage could impact diagnosis

    BD said reduced availability of blood culture media bottles due tosupplier issues has preventedit from meeting global demand.

    By Nick Paul Taylor July 11, 2024

  • Medtronic recalls endotracheal tubes over blockage risk

    The Food and Drug Administration has told healthcare providers to stop using the two affected types of endotracheal tubes.

    By Nick Paul Taylor July 11, 2024

  • Federal officials step down from health AI group’s board

    HHS officials Micky Tripathi and Troy Tazbaz resigned from their roles as non-voting members of the Coalition for Health AI, an industry group working to create standards for artificial intelligence in healthcare.

    By Emily Olsen • July 10, 2024

  • Roche wins CE mark for its first CGM

    The clearance positions Roche to challenge Abbott and Dexcom for the European continuous glucose monitormarket.

    By Nick Paul Taylor Updated July 10, 2024

  • Pulse drops 510(k) plan for PFA device after FDA requests clinical data

    Analysts said the AFib device is now unlikely to come to market before late 2026.

    By Nick Paul Taylor July 9, 2024

More stories
Medical Device News | MedTech Dive (2024)
Top Articles
Latest Posts
Article information

Author: Fredrick Kertzmann

Last Updated:

Views: 5677

Rating: 4.6 / 5 (66 voted)

Reviews: 81% of readers found this page helpful

Author information

Name: Fredrick Kertzmann

Birthday: 2000-04-29

Address: Apt. 203 613 Huels Gateway, Ralphtown, LA 40204

Phone: +2135150832870

Job: Regional Design Producer

Hobby: Nordic skating, Lacemaking, Mountain biking, Rowing, Gardening, Water sports, role-playing games

Introduction: My name is Fredrick Kertzmann, I am a gleaming, encouraging, inexpensive, thankful, tender, quaint, precious person who loves writing and wants to share my knowledge and understanding with you.